Modified EPOCH for high‐risk non‐Hodgkin lymphoma in sub‐Saharan Africa

Aggressive non‐Hodgkin lymphoma (NHL) is among the most common cancers in sub‐Saharan Africa (SSA), where CHOP is standard treatment and outcomes are poor. To address this, we treated 17 newly diagnosed adult patients in Malawi with Burkitt (n = 8), plasmablastic (n = 8), and primary effusion lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuze, Takondwa, Ellis, Grace K., Kasonkanji, Edwards, Kaimila, Bongani, Nyasosela, Richard, Nyirenda, Ruth, Tomoka, Tamiwe, Mulenga, Maurice, Chikasema, Maria, Tewete, Blessings, Mtangwanika, Asekanadziwa, Chiyoyola, Sarah, Chimzimu, Fred, Kampani, Coxcilly, Mhango, Wilberforce, Nicholas, Simon, Randall, Cara, Montgomery, Nathan D., Fedoriw, George, Westmoreland, Katherine D., Painschab, Matthew S., Gopal, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943163/
https://www.ncbi.nlm.nih.gov/pubmed/31705618
http://dx.doi.org/10.1002/cam4.2631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943163/
https://www.ncbi.nlm.nih.gov/pubmed/31705618
http://dx.doi.org/10.1002/cam4.2631

Ejemplares similares